Clinical Trials Directory

Trials / Unknown

UnknownNCT06059833

Serum Magnesium Level in Type 2 Diabetes Mellitus

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
Female
Age
30 Years
Healthy volunteers

Summary

Diabetes mellitus (DM) is a chronic metabolic disorder characterized by persistent hyperglycemia. It may be due to impaired insulin secretion, resistance to peripheral actions of insulin, or both . Chronic hyperglycemia in synergy with the other metabolic aberrations in patients with diabetes mellitus can cause damage to various organ systems, leading to the development of disabling and life-threatening health complications, most prominent of which are microvascular (retinopathy, nephropathy, and neuropathy) and macrovascular complications leading to a 2-fold to 4-fold increased risk of cardiovascular diseases Mg2+ deficiency is usually identified by the measurement of serum Mg2+ concentration. Hypomagnesemia is defined by a serum Mg2+ concentration \< 0.75 mmol/L, but a deficiency due to low dietary intake in otherwise healthy people is uncommon. Although overt signs of clinical Mg2+ deficiency are not routinely recognized in the healthy population, relatively low Mg2+ intake and/or Mg2+ status have been shown to be associated with chronic diseases, including cardiovascular disease, T2DM, osteoporosis, pulmonary disease, depression, migraine headaches, inflammation, and cancer

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMagnesiumThe aim of the study is to evaluate serum Mg level in type 2 DM patients.

Timeline

Start date
2023-09-01
Primary completion
2024-09-01
Completion
2024-09-01
First posted
2023-09-29
Last updated
2023-09-29

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06059833. Inclusion in this directory is not an endorsement.